General Information of the Compound
| Compound ID |
CP0569250
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[2-[2-[2-[3-[[5-[(3R)-4-(5-acetylpyridin-2-yl)-3-methylpiperazine-1-carbonyl]-3-methylthieno[2,3-c]pyrazol-1-yl]methyl]phenoxy]ethoxy]ethoxy]ethyl]-3-(2,2-difluoro-10,12-dimethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen-4-yl)propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C46H53BF2N8O6S
|
||||||||||||||||||
| Molecular Weight |
894.855
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1CN(CCN1c1ccc(cn1)C(C)=O)C(=O)c1cc2c(C)nn(Cc3cccc(OCCOCCOCCNC(=O)CCC4=[N+]5C(C=C4)=Cc4c(C)cc(C)n4[B-]5(F)F)c3)c2s1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C46H53BF2N8O6S/c1-30-23-31(2)56-41(30)25-38-11-10-37(57(38)47(56,48)49)12-14-44(59)50-15-18-61-19-20-62-21-22-63-39-8-6-7-35(24-39)29-55-46-40(33(4)52-55)26-42(64-46)45(60)53-16-17-54(32(3)28-53)43-13-9-36(27-51-43)34(5)58/h6-11,13,23-27,32H,12,14-22,28-29H2,1-5H3,(H,50,59)/t32-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LVVQHTDLANYFPE-JGCGQSQUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound